(Reuters) - Any way you look at it, AbbVie ABBV.N predecessor Abbott Laboratories ABT.N made a bad decision when it sued generic drug maker Perrigo PRGO.N in 2011, as Perrigo geared up to bring a ...

The FDA has approved Abbott’s AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

In a Complaint filed last Friday in the U.S. District Court for the District of Columbia, Perrigo Israel Pharmaceuticals Ltd. and Perrigo Company (collectively “Perrigo”) (represented by Hyman, Phelps ...

July 5 (Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone ...

DEAR DR. ROACH: I am an 84-year-old male. I recently switched from testosterone patches to AndroGel. My testosterone levels have gone up considerably, and I have seen some improvement in my erectile ...

Dear Dr. Roach • I am an 84-year-old male. I recently switched from testosterone patches to AndroGel. My testosterone levels have gone up considerably, and I have seen some improvement in my erectile ...

A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...

Advertisements for treatments for “low T,” or low testosterone levels in middle-aged and older men, have led to spikes in demand. But the safety and legitimacy of those testosterone therapies hasn’t ...